1. 3432 Metronomic cyclophosphamide (MC) treatment for heavily pre-treated metastatic Soft Tissue Sarcoma (mSTS). (September 2015) Authors: Simon, P.; Calcagno, F.; Klajer, E.; Meynard, G.; Delroeux, D.; Aubry, S.; Pauchot, J.; Valmary-Degano, S.; Nerich, V.; Kalbacher, E.; Isambert, N.; Chaigneau, L. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S698 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis. (November 2022) Authors: Curtit, E.; Bellanger, M.; Nerich, V.; Hequet, D.; Frenel, J.S.; Cristeau, O.; Rouzier, R. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Incidence and risk‐factors of CHOP/R‐CHOP‐related cardiotoxicity in patients with aggressive non‐Hodgkin's lymphoma. (3rd January 2014) Authors: Limat, S.; Daguindau, E.; Cahn, J.‐Y.; Nerich, V.; Brion, A.; Perrin, S.; Woronoff‐Lemsi, M.‐C.; Deconinck, E. Journal: Journal of clinical pharmacy and therapeutics Issue: Volume 39:Number 2(2014:Apr.) Page Start: 168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗